131 related articles for article (PubMed ID: 21618521)
1. Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
Lucas S; van Baren N; de Smet C; Coulie PG
Int J Cancer; 2012 Apr; 130(8):1960-6. PubMed ID: 21618521
[TBL] [Abstract][Full Text] [Related]
2. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
3. Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents.
de Vries IJ; Castelli C; Huygens C; Jacobs JF; Stockis J; Schuler-Thurner B; Adema GJ; Punt CJ; Rivoltini L; Schuler G; Coulie PG; Lucas S
Clin Cancer Res; 2011 Feb; 17(4):841-8. PubMed ID: 21177412
[TBL] [Abstract][Full Text] [Related]
4. FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue.
Schultze FC; Andag R; Alwahsh SM; Toncheva D; Maslyankov S; Yaramov N; von Ahsen N; Brandhorst G; Walson PD; Oellerich M; Petrova DT
Clin Biochem; 2014 Feb; 47(3):201-5. PubMed ID: 24291052
[TBL] [Abstract][Full Text] [Related]
5. Comparison of stable human Treg and Th clones by transcriptional profiling.
Stockis J; Fink W; François V; Connerotte T; de Smet C; Knoops L; van der Bruggen P; Boon T; Coulie PG; Lucas S
Eur J Immunol; 2009 Mar; 39(3):869-82. PubMed ID: 19224638
[TBL] [Abstract][Full Text] [Related]
6. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans.
Waight JD; Takai S; Marelli B; Qin G; Hance KW; Zhang D; Tighe R; Lan Y; Lo KM; Sabzevari H; Hofmeister R; Wilson NS
J Immunol; 2015 Feb; 194(3):878-82. PubMed ID: 25548231
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C Facilitates Demethylation of the Foxp3 Enhancer in a Tet-Dependent Manner.
Sasidharan Nair V; Song MH; Oh KI
J Immunol; 2016 Mar; 196(5):2119-31. PubMed ID: 26826239
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms of regulation of Foxp3 expression.
Lal G; Bromberg JS
Blood; 2009 Oct; 114(18):3727-35. PubMed ID: 19641188
[TBL] [Abstract][Full Text] [Related]
10. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.
Jia L; Zhu L; Wang JZ; Wang XJ; Chen JZ; Song L; Wu YJ; Sun K; Yuan ZY; Hui R
Atherosclerosis; 2013 Jun; 228(2):346-52. PubMed ID: 23566804
[TBL] [Abstract][Full Text] [Related]
11. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
13. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.
Baron U; Floess S; Wieczorek G; Baumann K; Grützkau A; Dong J; Thiel A; Boeld TJ; Hoffmann P; Edinger M; Türbachova I; Hamann A; Olek S; Huehn J
Eur J Immunol; 2007 Sep; 37(9):2378-89. PubMed ID: 17694575
[TBL] [Abstract][Full Text] [Related]
14. FOXP3 promoter demethylation reveals the committed Treg population in humans.
Janson PC; Winerdal ME; Marits P; Thörn M; Ohlsson R; Winqvist O
PLoS One; 2008 Feb; 3(2):e1612. PubMed ID: 18286169
[TBL] [Abstract][Full Text] [Related]
15. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
[TBL] [Abstract][Full Text] [Related]
16. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus.
Toker A; Engelbert D; Garg G; Polansky JK; Floess S; Miyao T; Baron U; Düber S; Geffers R; Giehr P; Schallenberg S; Kretschmer K; Olek S; Walter J; Weiss S; Hori S; Hamann A; Huehn J
J Immunol; 2013 Apr; 190(7):3180-8. PubMed ID: 23420886
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation controls Foxp3 gene expression.
Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
[TBL] [Abstract][Full Text] [Related]
19. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
Sahin E; Sahin M
J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications.
Iizuka-Koga M; Nakatsukasa H; Ito M; Akanuma T; Lu Q; Yoshimura A
J Autoimmun; 2017 Sep; 83():113-121. PubMed ID: 28709726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
